Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion type Assertion NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_head.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion evidence source_evidence_literature NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion SIO_000772 18299447 NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion wasDerivedFrom befree-2016 NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion wasGeneratedBy ECO_0000203 NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.